Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Waist of time and money
View:
Post by Momo25 on Jan 05, 2023 8:54am

Waist of time and money

I wonder why it took them 2 years and millions of dollars to finally realizing the only assets they have are the legacy drugs. Personnally, I was vocal against their oncology program because of their constant lying. They said they have seen in one cancer a tumor shrink by 58% meaning there is efficacy. If this is the case why saying in their last communication they are making pause because efficacy is not worth it.
I hope this gate approach is not a new way of spending money in programs that go nowhere. They should make the company profitable, generate enough cash then find a partner to take over. Paul Levesque and this board are definitely unfit for the job.
Comment by qwerty22 on Jan 05, 2023 9:53am
If you think having 3-5 tumours in one patient shrink by an average of 58% meant they'd cracked it then that's your problem not theirs. They were extremely cautious around that data. At the time I thought they were too cautious and should have made slightly bolder statements, that was just my opinion. At no point did they link what they saw to proof of concept or proof of efficacy. My ...more  
Comment by palinc2000 on Jan 05, 2023 10:29am
Qwerty I think you are right on...This MB has turned into a moaning platform because  uninitiated posters have  taken fantasies posted by others as facts....and interpreting the company s comments as coded terms of success , Nobody is happy with the SP but gees people need to look in the mirror for taking responsibility for their investment decision    What is  an ...more  
Comment by Momo25 on Jan 05, 2023 2:22pm
This post has been removed in accordance with Community Policy
Comment by palinc2000 on Jan 05, 2023 2:53pm
You really fit the description of un educated and uninitiated!!!!! Show me one post in my hundreds  of posts where I pretended to or made comments about being a scientist!!!  In my book JFM has very little knowledge in clinical trials and he makes observations in a vacuum in a fantasy world.... He has gone from the Sort1 platform   and Th1902 not getting any traction in the ...more  
Comment by Momo25 on Jan 05, 2023 3:21pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities